• Several months after Exscientia merger, AI biotech outfit Recursion reworks pipeline Fierce Biotech Mon, 05 May 2025 15:00:00 GMT
• recursion and exscientia merge, create new drug discovery company CHEManager Tue, 29 Apr 2025 06:42:36 GMT
• levi & korsinsky reminds exscientia investors of the pending class action lawsuit with a lead plaintiff deadline of june 25, 2024 ... ACCESS Newswire Tue, 08 Apr 2025 06:09:30 GMT
• investors in exscientia plc should contact levi & korsinsky before june 25, 2024 to discuss your rights - exai ACCESS Newswire Tue, 08 Apr 2025 02:48:34 GMT
• exscientia plc (nasdaq: exai) deadline alert: bernstein liebhard llp reminds exscientia plc investors of upcoming deadline ACCESS Newswire Sat, 05 Apr 2025 13:41:59 GMT
• 12 AI drug discovery companies you need to watch in 2025 Labiotech.eu Thu, 27 Mar 2025 07:00:00 GMT
• levi & korsinsky announces an investigation on behalf of exscientia plc (exai) shareholders who may have been affected by fraud ACCESS Newswire Tue, 25 Mar 2025 12:53:51 GMT
• HAYA Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer Business Wire Thu, 13 Mar 2025 07:00:00 GMT
• exai investor alert: bronstein, gewirtz & grossman llc announces that exscientia p.l.c. investors can join the class action lawsui... ACCESS Newswire Mon, 03 Mar 2025 22:35:55 GMT
• levi & korsinsky notifies exscientia plc investors of a class action lawsuit and upcoming deadline - exai ACCESS Newswire Mon, 03 Mar 2025 21:49:15 GMT
• exscientia plc sued for securities law violations - contact levi & korsinsky before june 25, 2024 to discuss your rights - exai ACCESS Newswire Mon, 03 Mar 2025 03:48:38 GMT
• upcoming exai deadline: bronstein, gewirtz & grossman llc reminds exscientia p.l.c. investors to join the class action lawsuit! ACCESS Newswire Sun, 02 Mar 2025 21:01:28 GMT
• shareholders of exscientia plc should contact levi & korsinsky before june 25, 2024 to discuss your rights - exai ACCESS Newswire Sat, 01 Mar 2025 21:37:07 GMT
• levi & korsinsky announces the filing of a securities class action on behalf of exscientia plc (exai) shareholders ACCESS Newswire Sat, 01 Mar 2025 02:17:28 GMT
• exai deadline alert: bernstein liebhard llp reminds exscientia plc investors of upcoming deadline ACCESS Newswire Sat, 01 Mar 2025 01:41:11 GMT
• shareholders that lost money on exscientia plc(exai) urged to join class action - contact levi & korsinsky to learn more ACCESS Newswire Fri, 28 Feb 2025 22:09:57 GMT
• recursion provides business updates and reports fourth quarter and fiscal year 2024 financial results Taiwan News Fri, 28 Feb 2025 11:30:00 GMT
• shareholders that lost money on exscientia plc (exai) urged to join class action - contact levi & korsinsky to learn more ACCESS Newswire Fri, 28 Feb 2025 10:05:47 GMT
• Levi & Korsinsky Reminds Exscientia plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 25, 2... ACCESS Newswire Fri, 28 Feb 2025 08:30:16 GMT
• levi & korsinsky reminds exscientia investors of the pending class action lawsuit with a lead plaintiff deadline of june 25, 2024 ... ACCESS Newswire Fri, 28 Feb 2025 08:00:26 GMT
• shareholder investigation: the m&a class action firm investigates the mergers and imminent votes of rxrx and exai ACCESS Newswire Fri, 28 Feb 2025 05:32:02 GMT
• levi & korsinsky reminds shareholders of a lead plaintiff deadline of june 25, 2024 in exscientia lawsuit - exai ACCESS Newswire Fri, 28 Feb 2025 02:24:58 GMT
• AI deals are surging, and Recursion’s ongoing Exscientia merger points to a new world of integration Pharma Voice Thu, 27 Feb 2025 08:00:00 GMT
• An Investigation Has Commenced on Behalf of Exscientia plc Shareholders. Contact Levi & Korsinsky to Discuss your EXAI Losses. ACCESS Newswire Thu, 27 Feb 2025 07:22:14 GMT
• shareholders of exscientia plc should contact levi & korsinsky before june 25, 2024 to discuss your rights - exai ACCESS Newswire Thu, 27 Feb 2025 07:17:46 GMT
• exscientia plc (nasdaq: exai) deadline alert: bernstein liebhard llp reminds exscientia plc investors of upcoming deadline ACCESS Newswire Mon, 24 Feb 2025 02:13:19 GMT
• levi & korsinsky reminds shareholders of a lead plaintiff deadline of june 25, 2024 in exscientia lawsuit - exai ACCESS Newswire Sat, 22 Feb 2025 10:00:42 GMT
• investors who lost money on exscientia plc(exai) should contact levi & korsinsky about pending class action - exai ACCESS Newswire Thu, 20 Feb 2025 11:18:29 GMT
• exai deadline alert: bernstein liebhard llp reminds exscientia plc investors of upcoming deadline ACCESS Newswire Thu, 20 Feb 2025 05:03:07 GMT
• exai shareholder alert: bronstein, gewirtz & grossman llc reminds exscientia p.l.c. investors to join the class action lawsuit ACCESS Newswire Thu, 20 Feb 2025 03:06:18 GMT
• exai shareholder alert: bronstein, gewirtz & grossman llc reminds exscientia p.l.c. investors to join the class action lawsuit ACCESS Newswire Mon, 10 Feb 2025 23:07:19 GMT
• exai investor alert: bronstein, gewirtz & grossman llc announces that exscientia p.l.c. investors can join the class action lawsui... ACCESS Newswire Mon, 10 Feb 2025 17:20:09 GMT
• upcoming exai deadline: bronstein, gewirtz & grossman llc reminds exscientia p.l.c. investors to join the class action lawsuit ACCESS Newswire Mon, 03 Feb 2025 14:52:54 GMT
• upcoming exai deadline: bronstein, gewirtz & grossman llc reminds exscientia p.l.c. investors to join the class action lawsuit! ACCESS Newswire Tue, 28 Jan 2025 00:30:30 GMT
• final exai deadline: bronstein, gewirtz & grossman llc reminds exscientia p.l.c. investors to join the class action lawsuit ACCESS Newswire Sun, 26 Jan 2025 23:15:22 GMT
• exscientia plc sued for securities law violations - investors should contact levi & korsinsky for more information - exai ACCESS Newswire Sun, 26 Jan 2025 15:11:23 GMT
• exscientia plc sued for securities law violations - investors sh GuruFocus.com Mon, 20 Jan 2025 18:35:03 GMT
• jpm25: recursion $rxrx - by albert - rhymes with haystack substack.com Wed, 15 Jan 2025 09:47:15 GMT
• Iambic snatches CFO Michael Secora, who steered Recursion-Exscientia deal Medical Marketing and Media Mon, 06 Jan 2025 08:00:00 GMT
• Exclusive: AI biotech Iambic snags CFO who helped steer Recursion-Exscientia deal Endpoints News Mon, 06 Jan 2025 08:00:00 GMT
• AI Accelerates and Expands Drug Development Genetic Engineering and Biotechnology News Mon, 06 Jan 2025 08:00:00 GMT
• recursion ceo to present pipeline and platform updates at jp morgan healthcare conference StockTitan Mon, 06 Jan 2025 08:00:00 GMT
• rxrx recursion pharma enters 2025 ahead of the techbio curve substack.com Thu, 02 Jan 2025 11:14:36 GMT
• recursion pharmaceuticals reports grant of inducement awards as permitted by the nasdaq listing rules The Manila Times Fri, 20 Dec 2024 21:27:36 GMT
• exscientia's swot analysis: ai biotech stock faces merger challenges Investing.com Sun, 15 Dec 2024 08:00:00 GMT
• recursion pharmaceuticals’ (rxrx) bold acquisition places it as an industry leader TipRanks Tue, 03 Dec 2024 14:14:26 GMT
• Recursion Pharmaceuticals CFO Ben Taylor to Join Exscientia TipRanks Tue, 03 Dec 2024 08:00:00 GMT
• dundee university made £40m windfall thanks to artificial intelligence company The Courier Mon, 02 Dec 2024 06:00:42 GMT
• revolutionizing drug discovery: how exscientia and aws are redefining innovation with generative ai Analytics Insight Sun, 01 Dec 2024 19:19:27 GMT
• this week in ai research: amazon launches 2t parameter video model, mount sinai opens ai center, recursion-exscientia close merger... R&D World Fri, 29 Nov 2024 05:07:44 GMT
• This week in AI research: Amazon launches 2T parameter video model, Mount Sinai opens AI center, Recursion-Exscientia close merger... R&D World Thu, 28 Nov 2024 08:00:00 GMT
• recursion reduces workforce; oxford nanopore teams up with uk biobank Endpoints News Wed, 27 Nov 2024 08:00:00 GMT
• recursion, the ai drug development company, cuts more jobs after finalizing exscientia merger STAT Wed, 27 Nov 2024 00:58:17 GMT
• Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger statnews.com Tue, 26 Nov 2024 08:00:00 GMT
• stockwatch: moderna seeks to reassure investors on rfk jr. Genetic Engineering & Biotechnology News Sun, 24 Nov 2024 18:20:30 GMT
• exscientia's swot analysis: ai-driven biotech stock faces merger challenges by investing.com Investing.com Australia Sat, 23 Nov 2024 08:34:54 GMT
• Exscientia confirms £500 million merger with Recursion insider.co.uk Fri, 22 Nov 2024 08:00:00 GMT
• exscientia plc (exai) stock price, quote, news & analysis Seeking Alpha Fri, 22 Nov 2024 07:36:19 GMT
• exscientia merges with recursion to create integrated drug discovery platform World Pharmaceutical Frontiers Thu, 21 Nov 2024 08:00:00 GMT
• recursion-exscientia merger creates advanced ai-driven drug discovery Bernama Thu, 21 Nov 2024 08:00:00 GMT
• exscientia's swot analysis: ai-driven biotech stock faces merger challenges Investing.com Thu, 21 Nov 2024 08:00:00 GMT
• recursion and exscientia, two leaders in the ai drug discovery space, have officially combined to advance the industrialization of... BERNAMA Thu, 21 Nov 2024 03:51:04 GMT
• trans-atlantic triumph: ai drug pioneers recursion, exscientia combine Genetic Engineering & Biotechnology News Thu, 21 Nov 2024 02:29:58 GMT
• dundee ai drug company born in city coffee shop sold for £500m The Courier Wed, 20 Nov 2024 17:54:07 GMT
• Trans-Atlantic Triumph: AI Drug Pioneers Recursion, Exscientia Combine Genetic Engineering and Biotechnology News Wed, 20 Nov 2024 08:00:00 GMT
• Exscientia and Recursion Merge to Revolutionize Drug Discovery TipRanks Wed, 20 Nov 2024 08:00:00 GMT
• Recursion Pharmaceuticals’ Strategic Acquisition and Leadership Changes TipRanks Wed, 20 Nov 2024 08:00:00 GMT
• recursion, exscientia officially combine to advance drug discovery TipRanks Wed, 20 Nov 2024 08:00:00 GMT
• recursion - no news isn't good news when it comes to vanilla pipeline (nasdaq:rxrx) Seeking Alpha Wed, 20 Nov 2024 08:00:00 GMT
• recursion completes exscientia merger, creates ai drug discovery powerhouse with $20b+ pipeline StockTitan Wed, 20 Nov 2024 08:00:00 GMT
• what programs did recursion (rxrx) deprioritize after the exscientia merger? StockTitan Wed, 20 Nov 2024 08:00:00 GMT
• exscientia (nasdaq:exai) shares down 5.3% - time to sell? MarketBeat Fri, 15 Nov 2024 18:27:45 GMT
• exscientia (nasdaq:exai) trading down 5.3% - should you sell? MarketBeat Fri, 15 Nov 2024 08:00:00 GMT
• recursion and exscientia shareholders approve the proposed combination Utah Business Thu, 14 Nov 2024 08:00:00 GMT
• recursion pharmaceuticals secures stockholder nod for exscientia acquisition Investing.com Thu, 14 Nov 2024 02:47:20 GMT
• recursion, exscientia shareholders back merger by investing.com Investing.com Canada Wed, 13 Nov 2024 20:04:18 GMT
• baillie gifford & co. sells 549,342 shares of exscientia plc (nasdaq:exai) MarketBeat Wed, 13 Nov 2024 11:19:38 GMT
• baillie gifford & co. has $18.78 million stake in exscientia plc (nasdaq:exai) MarketBeat Wed, 13 Nov 2024 11:19:38 GMT
• recursion, exscientia shareholders approve proposed combination TipRanks Wed, 13 Nov 2024 08:00:00 GMT
• recursion and exscientia shareholders approve the proposed combination Yahoo Finance Wed, 13 Nov 2024 08:00:00 GMT
• recursion & exscientia merger approved: ai drug discovery giants set to unite StockTitan Wed, 13 Nov 2024 08:00:00 GMT
• recursion pharmaceuticals secures stockholder nod for exscientia acquisition Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• exscientia (nasdaq:exai) sees large volume increase - here's why MarketBeat Mon, 11 Nov 2024 18:25:11 GMT
• exscientia plc reports earnings results for the third quarter and nine months ended september 30, 2024 Marketscreener.com Fri, 08 Nov 2024 11:41:00 GMT
• exscientia plc faces financial challenges amid rising costs TipRanks Fri, 08 Nov 2024 08:00:00 GMT
• Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results GlobeNewswire Wed, 06 Nov 2024 08:00:00 GMT
• recursion's q3 revenue soars 148% to $26.1m, lands $30m roche deal amid clinical wins StockTitan Wed, 06 Nov 2024 08:00:00 GMT
• recursion to report third quarter 2024 business updates and financial results on november 6th The Manila Times Wed, 30 Oct 2024 07:00:00 GMT
• small cap stocks: recursion pharmaceuticals (rxrx) applying ai and strategic partnerships MSN Sat, 26 Oct 2024 11:16:54 GMT
• lost money on exscientia plc(exai)? join class action suit seeki GuruFocus.com Wed, 23 Oct 2024 02:46:20 GMT
• exscientia to receive $15m in milestones for sanofi collaboration MSN Sat, 19 Oct 2024 18:37:07 GMT
• exscientia plc (nasdaq:exai) sees large decrease in short interest MarketBeat Fri, 18 Oct 2024 03:34:48 GMT
• exscientia and sanofi announce discovery program progress BioWorld Online Thu, 17 Oct 2024 07:00:00 GMT
• exscientia advances two additional discovery programs with sanofi Yahoo Finance Thu, 17 Oct 2024 07:00:00 GMT
• exscientia plc (nasdaq:exai) sees large decrease in short interest MarketBeat Thu, 17 Oct 2024 07:00:00 GMT
• exscientia focus firmly on pipeline after ceo exit scandal insights.citeline.com Wed, 16 Oct 2024 08:45:37 GMT
• exscientia achieves milestones for two programmes in sanofi collaboration Business Wire Wed, 16 Oct 2024 07:00:00 GMT
• exscientia advances two drug programs with sanofi by investing.com Investing.com UK Wed, 16 Oct 2024 07:00:00 GMT
• exscientia to receive $15m in milestones for sanofi collaboration (nasdaq:exai) Seeking Alpha Wed, 16 Oct 2024 07:00:00 GMT
• exscientia advances two additional discovery programs with sanofi TipRanks Wed, 16 Oct 2024 07:00:00 GMT
• exscientia’s $15m milestone from sanofi; lilly to take gateway labs to china Endpoints News Wed, 16 Oct 2024 07:00:00 GMT
• recursion’s all-stock acquisition of exscientia plc (exai): nvidia-backed merger to revolutionize ai-driven drug discovery Insider Monkey Sat, 12 Oct 2024 00:59:08 GMT
• Recursion’s All-Stock Acquisition of Exscientia plc (EXAI): NVIDIA-Backed Merger to Revolutionize AI-Driven Drug Discovery Yahoo Finance Fri, 11 Oct 2024 07:00:00 GMT
• shareholder investigation: the m&a class action firm investigates the mergers and imminent votes of rxrx and exai AccessWire Fri, 11 Oct 2024 07:00:00 GMT
• recursion, exscientia seek support for merger ahead of special meeting Seeking Alpha Thu, 10 Oct 2024 07:00:00 GMT
• ai biotechs recursion and exscientia first held deal talks in 2022 Endpoints News Thu, 10 Oct 2024 07:00:00 GMT
• exscientia to present new preclinical data for ai-designed lsd1 and malt1 inhibitors at ena 2024 BioSpace Wed, 09 Oct 2024 07:00:00 GMT
• harrow (hrow) surges 8.4%: is this an indication of further gains? MSN Sun, 06 Oct 2024 12:43:30 GMT
• Exscientia outline robot and AI use in drug discovery workflow Pharmaceutical Technology Wed, 02 Oct 2024 07:00:00 GMT
• 13,086,600 shares in exscientia plc (nasdaq:exai) bought by novo holdings a s MarketBeat Mon, 30 Sep 2024 12:14:09 GMT
• data demonstrating enpp1 inhibition as a therapeutic approach for later-onset hypophosphatasia presented at the american society f... StockTitan Mon, 30 Sep 2024 12:00:00 GMT
• exscientia's swot analysis: ai biotech stock faces merger, pipeline milestones Investing.com Mon, 30 Sep 2024 07:00:00 GMT
• bank of new york mellon corp raises stock position in exscientia plc (nasdaq:exai) MarketBeat Wed, 18 Sep 2024 09:45:56 GMT
• bank of new york mellon corp raises holdings in exscientia plc (nasdaq:exai) MarketBeat Wed, 18 Sep 2024 09:45:56 GMT
• bank of new york mellon corp buys 202,377 shares of exscientia plc (nasdaq:exai) MarketBeat Wed, 18 Sep 2024 09:45:56 GMT
• shareholders that lost money on exscientia plc(exai) should contact the gross law firm about pending class action - exai Longview News-Journal Fri, 06 Sep 2024 03:11:24 GMT
• rosen, leading investor counsel, encourages exscientia GlobeNewswire Thu, 05 Sep 2024 07:00:00 GMT
• Recursion’s Ambitions: Developing 100+ Candidates, Joining with Exscientia Genetic Engineering and Biotechnology News Wed, 04 Sep 2024 07:00:00 GMT
• recursion shares fall after phase ii data for rec-994 The Pharma Letter Wed, 04 Sep 2024 07:00:00 GMT
• exscientia (nasdaq:exai) sees unusually-high trading volume MarketBeat Tue, 03 Sep 2024 19:38:54 GMT
• Recursion’s CEO Discusses Pipeline Growth, Approach to AI and ML Genetic Engineering and Biotechnology News Tue, 03 Sep 2024 07:00:00 GMT
• Recursion Pharmaceuticals Proposes Strategic Exscientia Merger TipRanks Tue, 03 Sep 2024 07:00:00 GMT
Exscientia plc(NASDAQ:EXAI) 
Exscientia Limited, an artificial intelligence-powered pharmaceutical technology company, is dedicated to drug discovery, design and development. The company is headquartered in Oxford, the United Kingdom.
Website: https://www.exscientia.ai/
Founded: 2012
IPO Price: $22 (Oct 01, 2021)
CEO / Founder: Andrew Hopkins
Sector:
Industry: